宁波三星医疗电气股份有限公司对外担保决策制度详解及投资者关注要点

主要内容概述

宁波三星医疗电气股份有限公司（以下简称“三星医疗电气”）最新发布了《对外担保决策制度（草案）》，该制度将于公司H股发行并在香港联合交易所上市后正式实施。此次制度的制定，旨在加强公司银行信用与担保管理，规范对外担保行为，防范和降低经营风险，进一步保障投资者和公司利益。

对投资者和股东的重要影响点

• 对外担保需严格审批： 公司所有对外担保事项需经董事会或股东会审议。部分重要情形（如大额担保、关联方担保等）需经董事会通过后再提交股东会审议。这一制度大幅提升了对外担保事项的决策门槛，有助于避免盲目担保可能带来的风险隐患。
• 重大担保事项的具体范围：
  • 当公司及其控股子公司对外担保总额达到或超过最近一期经审计净资产50%后新增的任何担保；
  • 公司对外担保总额达到或超过最近一期经审计总资产30%后新增的任何担保；
  • 公司在一年内担保金额超过最近一期经审计总资产30%的担保；
  • 为资产负债率超过70%的担保对象提供担保；
  • 单笔担保额超过最近一期经审计净资产10%的担保；
  • 为股东、实际控制人及其关联人提供的担保；
  • 交易所规定的其他情形。
• 关联方及大额担保需特别审议： 相关重大担保事项需经出席董事会三分之二以上董事同意，并提交股东会审议。为关联方担保还需非关联董事三分之二以上同意，且在股东会表决时，关联股东需回避表决。这有助于防止大股东、实际控制人及其关联方通过公司资源为自身利益输送，进一步保护中小股东权益。
• 反担保措施及责任追究： 公司为控股股东、实际控制人及其关联人提供担保时，必须获得相应反担保。若董事会或股东会违反审批权限和程序，相关董事、股东需承担连带责任，公司有权视损失和风险程度追究其责任。
• 董事和分支机构不得越权签约： 未经授权，董事、总裁及分支机构不得代表公司签署对外担保合同，防止无序担保发生。
• 严格筛选与管理被担保对象： 公司仅为与自身业务往来密切、资信状况良好的企业提供担保，且担保额度需与实际业务往来匹配。公司还要求审慎审查担保合同条款，定期收集被担保方财务资料并动态跟踪风险。
• 信息披露义务： 公司将严格按照证券法及上市地法律法规，在发生重大担保事项时及时履行信息披露义务，保障市场透明与投资者知情权。

潜在对股价的影响及投资者需关注的事项

本次《对外担保决策制度》的出台，体现了公司合规治理、风险防控意识的增强。对于投资者而言，以下几方面可能影响股价表现：

• 提升公司治理水平： 严格的担保决策流程有助于提升公司整体风险管理能力，减少因担保引发的财务和声誉风险，增强投资者信心，或为公司估值带来正面影响。
• 减少大股东侵占公司资源的空间： 对与控股股东、实际控制人及其关联方担保的严格限制，能够有效防止利益输送，维护中小股东利益，或受市场积极解读。
• 担保事项透明化： 重大担保需信息披露，有利于市场及时了解公司对外风险敞口，提升公司信息透明度，减少“黑天鹅”事件概率。
• 潜在风险提示： 若未来公司对外担保规模大幅提升，仍可能对公司财务安全带来压力，投资者需持续关注相关披露信息。

投资者特别提示

• 本制度如有与新法律法规或公司章程冲突，按新规定执行。
• 制度自H股发行在港交所挂牌之日起生效，由公司董事会负责解释与实施。

免责声明

以上内容仅供投资者参考，不构成任何投资建议。投资者应结合自身情况独立判断，并注意投资风险。公司未来担保事项的具体实施情况，仍需以公司公告为准。

English Translation

Detailed Analysis of Ningbo Sanxing Medical Electric’s External Guarantee Decision System and Key Points for Investors

Main Highlights

Ningbo Sanxing Medical Electric Co., Ltd. (“Sanxing Medical Electric”) has recently published its draft “External Guarantee Decision System,” which will take effect after the company’s H-share issuance and listing on the Hong Kong Stock Exchange. The system aims to strengthen the company’s banking credit and guarantee management, regulate external guarantees, control and reduce operational risks, and further protect the interests of investors and the company.

Key Issues for Investors and Shareholders

• Strict Approval for External Guarantees: All external guarantees must be reviewed by the Board of Directors or Shareholders’ Meeting. Some significant circumstances (such as large guarantees, related-party guarantees, etc.) require Board approval before submission to the Shareholders’ Meeting. This significantly raises the decision-making threshold for external guarantees and helps prevent risks from reckless guarantees.
• Specific Scope of Major Guarantees:
  • Any new guarantee provided after the group’s total external guarantees (including subsidiaries) reach or exceed 50% of the most recent audited net assets;
  • Any new guarantee provided after the company’s total external guarantees reach or exceed 30% of the most recent audited total assets;
  • Guarantees provided within a year exceeding 30% of the most recent audited total assets;
  • Guarantees for parties with a debt-to-asset ratio over 70%;
  • Single guarantees exceeding 10% of most recent audited net assets;
  • Guarantees for shareholders, actual controllers, or their related parties;
  • Other cases specified by the Shanghai or Hong Kong Exchanges.
• Special Review for Related-Party and Large Guarantees: Major guarantees must be approved by at least two-thirds of attending directors and then submitted to the Shareholders’ Meeting. Guarantees for related parties also require two-thirds approval from non-related directors, and related shareholders must abstain from voting at the Shareholders’ Meeting. This prevents the misuse of company resources by major shareholders or controllers for their own benefit and helps protect minority shareholders.
• Counter-Guarantees and Accountability: Any guarantee for controlling shareholders, actual controllers, or related parties must be backed by counter-guarantees. Directors or shareholders who violate approval authorities and procedures are jointly liable and may be held responsible by the company based on losses, risk, and circumstances.
• Directors and Branches Cannot Sign Without Authorization: Directors, GMs, and branches cannot sign external guarantees without authorization, preventing unauthorized guarantees.
• Strict Selection and Management of Guaranteed Parties: The company only guarantees counterparties closely related to its business and with good credit. Guarantee amounts must match actual business volume, and contracts are carefully reviewed. The company tracks the financial condition and risk of guaranteed parties and reports regularly to the Board.
• Information Disclosure Obligations: The company will strictly fulfill information disclosure obligations in line with securities laws and listing regulations, ensuring market transparency and investor awareness.

Potential Impact on Share Price and Investor Focus

The new system demonstrates the company’s commitment to compliance and risk control. The following aspects may affect share price performance:

• Enhanced Corporate Governance: Stricter guarantee procedures improve risk management, reduce financial and reputational risks, and may boost investor confidence and company valuation.
• Reduced Space for Resource Misappropriation by Major Shareholders: Tight restrictions on related-party guarantees protect minority shareholders and may be viewed positively by the market.
• Greater Guarantee Transparency: Major guarantees must be disclosed, enabling timely market awareness of the company’s risk exposure and reducing the risk of surprise events.
• Risk Warning: If the company’s external guarantee scale increases sharply, financial risk may still rise. Investors should closely monitor further disclosures.

Special Notes for Investors

• If the system conflicts with new laws or the articles of association, new regulations will prevail.
• The system takes effect from the H-share listing on the HKEX and is interpreted and implemented by the Board.

Disclaimer

The above is for reference only and does not constitute investment advice. Investors should make independent judgments based on their own circumstances and beware of risks. For future guarantee matters, please refer to company announcements.

View 三星医疗 Historical chart here